Haemonetics Stock Forecast - Accumulation Distribution
| HAE Stock | USD 68.37 0.45 0.65% |
Haemonetics Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Haemonetics stock prices and determine the direction of Haemonetics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Haemonetics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, the value of RSI of Haemonetics' share price is approaching 43. This usually indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Haemonetics, making its price go up or down. Momentum 43
Sell Extended
Oversold | Overbought |
Using Haemonetics hype-based prediction, you can estimate the value of Haemonetics from the perspective of Haemonetics response to recently generated media hype and the effects of current headlines on its competitors.
Haemonetics after-hype prediction price | USD 68.37 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Haemonetics | Build AI portfolio with Haemonetics Stock |
Haemonetics Additional Predictive Modules
Most predictive techniques to examine Haemonetics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Haemonetics using various technical indicators. When you analyze Haemonetics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 28317.55 | 9475.75 |
| Check Haemonetics Volatility | Backtest Haemonetics | Information Ratio |
Haemonetics Trading Date Momentum
| On January 26 2026 Haemonetics was traded for 68.37 at the closing time. Highest Haemonetics's price during the trading hours was 68.91 and the lowest price during the day was 68.03 . The net volume was 742 K. The overall trading history on the 26th of January did not cause price change. The trading delta at closing time to current price is 0.63% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Haemonetics to competition |
Other Forecasting Options for Haemonetics
For every potential investor in Haemonetics, whether a beginner or expert, Haemonetics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Haemonetics Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Haemonetics. Basic forecasting techniques help filter out the noise by identifying Haemonetics' price trends.Haemonetics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Haemonetics stock to make a market-neutral strategy. Peer analysis of Haemonetics could also be used in its relative valuation, which is a method of valuing Haemonetics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Haemonetics Market Strength Events
Market strength indicators help investors to evaluate how Haemonetics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Haemonetics shares will generate the highest return on investment. By undertsting and applying Haemonetics stock market strength indicators, traders can identify Haemonetics entry and exit signals to maximize returns.
| Accumulation Distribution | 9475.75 | |||
| Daily Balance Of Power | (0.51) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 68.47 | |||
| Day Typical Price | 68.44 | |||
| Price Action Indicator | (0.32) | |||
| Period Momentum Indicator | (0.45) | |||
| Relative Strength Index | 43.36 |
Haemonetics Risk Indicators
The analysis of Haemonetics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Haemonetics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting haemonetics stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.82 | |||
| Semi Deviation | 1.47 | |||
| Standard Deviation | 4.5 | |||
| Variance | 20.21 | |||
| Downside Variance | 4.59 | |||
| Semi Variance | 2.16 | |||
| Expected Short fall | (1.96) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Haemonetics
The number of cover stories for Haemonetics depends on current market conditions and Haemonetics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Haemonetics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Haemonetics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Haemonetics Short Properties
Haemonetics' future price predictability will typically decrease when Haemonetics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Haemonetics often depends not only on the future outlook of the potential Haemonetics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Haemonetics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 50.7 M | |
| Cash And Short Term Investments | 306.8 M |
Check out Historical Fundamental Analysis of Haemonetics to cross-verify your projections. For information on how to trade Haemonetics Stock refer to our How to Trade Haemonetics Stock guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Haemonetics. If investors know Haemonetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Haemonetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Haemonetics is measured differently than its book value, which is the value of Haemonetics that is recorded on the company's balance sheet. Investors also form their own opinion of Haemonetics' value that differs from its market value or its book value, called intrinsic value, which is Haemonetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Haemonetics' market value can be influenced by many factors that don't directly affect Haemonetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Haemonetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Haemonetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Haemonetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.